Raynaud’s

Clinical Trials For BOTOX® Study

Southern Illinois University School of Medicine is currently recruiting Raynaud’s patients to participate in a clinical trial of BOTOX® therapy for chronic pain and ulcerations.  This is a 28-day randomized, double-blind, placebo-controlled clinical trial requiring travel to the clinic in Springfield, Illinois. 

2012-11-24T14:19:37-05:00September 27th, 2011|In The News|3 Comments

Summer 2011 Newsletter Is Out

It may be the first few days of Fall, but we'd all love to extend the Summer season.  We'd also like to have published our Summer issue of Cold Cuts sooner, but hope it's worth waiting for.   This is our first year with quarterly editions, so please bear with us as we work to double

2011-09-26T22:01:48-04:00September 26th, 2011|In The News, Site Information|Comments Off on Summer 2011 Newsletter Is Out

Raynaud’s Daydream Comes True

So happy to find you… A few days ago, I had a daydream that there was a support group for people like me (which I just discovered has an actual name). I was feeling so alone, so sad and so frustrated with the pain I feel from temperatures I experience as cold – but no

2011-10-26T23:07:50-04:00August 26th, 2011|Stories|3 Comments

Dress Codes in the Workplace and Raynaud’s

Just found this quote in a legal newsbrief about dress codes in the workplace as they relate to Raynaud’s.  We had a member a couple of years ago who was let go from a theatre as a volunteer for this very reason – wearing a sweater!

2011-08-02T21:00:57-04:00August 2nd, 2011|In The News, Stories|Comments Off on Dress Codes in the Workplace and Raynaud’s

Special Half-Price Offer on Volt Heated Slippers

We’ll soon be sharing some exciting news about the next generation Volt heated slippers that will be introduced this fall. For Frosties who want to get a jump on preparing for the upcoming cold season, the manufacturer still has a small supply of the original models in stock, and is making these toasty slippers available

2011-07-26T21:17:52-04:00July 26th, 2011|In The News|2 Comments
Go to Top